🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/07/1997 | 48,93 | 49,68 | 48,93 | 49,59 | +0,42% | 1,52% | 5.172.718 |
| 07/07/1997 | 50,10 | 50,16 | 48,84 | 49,38 | -1,60% | 2,62% | 5.600.512 |
| 03/07/1997 | 50,10 | 50,45 | 49,95 | 50,18 | +0,54% | 1,01% | 3.961.230 |
| 02/07/1997 | 49,98 | 50,07 | 49,20 | 49,92 | +0,54% | 1,73% | 3.942.157 |
| 01/07/1997 | 48,78 | 49,86 | 48,75 | 49,65 | +1,71% | 2,26% | 6.259.914 |
| 30/06/1997 | 48,96 | 49,38 | 47,95 | 48,81 | -0,18% | 2,92% | 5.071.482 |
| 27/06/1997 | 48,66 | 49,83 | 48,66 | 48,90 | +0,74% | 2,39% | 4.892.483 |
| 26/06/1997 | 48,66 | 49,14 | 48,19 | 48,54 | -1,03% | 1,96% | 4.688.123 |
| 25/06/1997 | 48,66 | 50,01 | 48,54 | 49,05 | -0,30% | 3,00% | 7.142.120 |
| 24/06/1997 | 47,89 | 49,32 | 47,71 | 49,20 | +4,56% | 3,36% | 6.946.563 |
| 23/06/1997 | 47,77 | 48,72 | 47,05 | 47,05 | -1,37% | 3,50% | 6.226.797 |
| 20/06/1997 | 47,59 | 48,54 | 47,53 | 47,71 | +0,25% | 2,13% | 12.060.594 |
| 19/06/1997 | 46,16 | 47,71 | 46,16 | 47,59 | +3,50% | 3,36% | 6.993.514 |
| 18/06/1997 | 46,28 | 46,70 | 45,68 | 45,98 | -1,28% | 2,19% | 4.332.432 |
| 17/06/1997 | 46,64 | 47,11 | 46,16 | 46,58 | -0,38% | 2,05% | 5.234.760 |
| 16/06/1997 | 47,17 | 47,23 | 46,76 | 46,76 | -0,63% | 1,01% | 4.897.514 |
| 13/06/1997 | 46,76 | 47,29 | 46,70 | 47,05 | +1,02% | 1,28% | 7.364.925 |
| 12/06/1997 | 46,04 | 46,76 | 45,92 | 46,58 | +1,96% | 1,81% | 6.146.520 |
| 11/06/1997 | 45,09 | 45,74 | 45,03 | 45,68 | +1,86% | 1,59% | 6.729.208 |
| 10/06/1997 | 44,91 | 45,38 | 44,43 | 44,85 | +0,53% | 2,12% | 6.629.438 |
| 09/06/1997 | 44,19 | 45,15 | 44,01 | 44,61 | +1,36% | 2,56% | 5.920.781 |
| 06/06/1997 | 42,70 | 44,19 | 42,64 | 44,01 | +3,36% | 3,63% | 5.482.298 |
| 05/06/1997 | 42,88 | 43,24 | 42,46 | 42,58 | +0,00% | 1,81% | 4.645.155 |
| 04/06/1997 | 42,94 | 43,30 | 42,58 | 42,58 | -0,83% | 1,67% | 3.314.195 |
| 03/06/1997 | 42,82 | 43,71 | 42,82 | 42,94 | +0,00% | 2,09% | 4.735.074 |
| 02/06/1997 | 43,00 | 43,24 | 42,58 | 42,94 | +0,14% | 1,53% | 6.642.853 |
| 30/05/1997 | 43,00 | 43,24 | 42,76 | 42,88 | -1,24% | 1,11% | 6.828.139 |
| 29/05/1997 | 43,89 | 44,25 | 43,18 | 43,42 | -1,09% | 2,45% | 4.010.906 |
| 28/05/1997 | 44,49 | 44,61 | 43,36 | 43,89 | -1,47% | 2,82% | 5.076.302 |
| 27/05/1997 | 44,37 | 44,79 | 44,25 | 44,55 | +0,40% | 1,21% | 4.225.326 |